ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,316Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 86

$271K Total Retail Price of All Prescriptions

Rank: 30 out of 86

232 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

25% of this provider’s 232 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 4,267 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LISINOPRIL 464 282 1 3
CLONIDINE HCL 393 222 2 28
HYDROCODONE-ACETAMINOPHEN 389 165 S3 3 1
GLIPIZIDE ER 308 187 4 90
LOVASTATIN 257 165 5 32
MELOXICAM 212 134 6 20
AMLODIPINE BESYLATE 183 127 7 4
ATENOLOL 173 82 8 16
RANITIDINE HCL 170 85 9 14
NIFEDIAC CC 164 118 10 177
FUROSEMIDE 159 108 11 5
GABAPENTIN 133 75 12 11
POTASSIUM CHLORIDE 131 61 13 10
NIFEDIPINE ER 126 81 14 84
NEXIUM 124 76 15 22
TRAMADOL HCL 120 74 16 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 103 76 17 21
CYCLOBENZAPRINE HCL 101 47 R 18 56
HYDROCHLOROTHIAZIDE 94 46 19 9
ADVAIR DISKUS 87 41 20 62
KLOR-CON M20 84 44 21 54
ZOLPIDEM TARTRATE 82 30 22 18
AMLODIPINE BESYLATE-BENAZEPRIL 77 33 23 67
METFORMIN HCL 75 34 24 8
IBUPROFEN 75 36 24 70
DOXAZOSIN MESYLATE 73 49 26 105
HYDRALAZINE HCL 73 68 26 52
NABUMETONE 72 38 28 180
PHENYTOIN SODIUM EXTENDED 70 26 29 123
LANTUS 70 56 29 40
ACARBOSE 66 34 31 224
SIMVASTATIN 65 39 32 2
FAMOTIDINE 65 31 32 35
OMEPRAZOLE 64 50 34 7
METFORMIN HCL ER 61 16 35 55
INSULIN SYRINGE 57 35 36 49
PAROXETINE HCL 57 19 36 63
KLOR-CON 10 56 40 38 95
ATORVASTATIN CALCIUM 54 28 39 17
DONEPEZIL HCL 53 44 40 41
LEVOTHYROXINE SODIUM 51 30 41 6
ALLOPURINOL 51 38 41 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.